Clinical Trial Update: Radotinib Versus Imatinib in Newly Diagnosed Philadelphia Chromosome and Chronic Myeloid Leukemia Chronic Phase Patients [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial comparing radotinib to imatinib in newly diagnosed Philadelphia chromosome-positive chronic phase chronic myeloid leukemia has comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• Imatinib (imatinib)
• Radotinib (radotinib)

Snippet

Sponsor: Il-Yang Pharm. Co., Ltd. | Conditions: Leukemia, Leukemia, Myeloid | Phase 3 | Status: COMPLETED